Canadian Glycomics Network

Home / About / Governance / Equity, Diversity, and Inclusion Committee

Equity, Diversity, and Inclusion Committee

The Equity, Diversity, and Inclusion Committee facilitates the development and maintenance of collaborative partnerships within GlycoNet to achieve a community in which group members are represented and participate equitably at all levels. The Committee works to implement the Network’s Equity, Diversity and Inclusion plan and raise awareness of inclusivity within GlycoNet.

The EDI Committee’s Terms of Reference was approved by the Board on July 8, 2020. Read the following message from the Chair of the EDI Committee:

Organizations that successfully embrace principles of equity, diversity, and inclusiveness (EDI) improve their creativity, productivity, and products. The Board of Directors of GlycoNet believes that, if we as a community support equity, diversity, and inclusiveness, we will improve the innovation and research outcomes within the network. Accordingly, the Board established the EDI Committee, which has representation from across the GlycoNet community and reports directly to the Board. Its mandate is broadly to recommend actions and programs that will enhance EDI throughout the network. Please read the Terms of Reference document and GlycoNet’s EDI Policy, and initiate discussions among your colleagues about what EDI means to you.

Sincerely,

Nils O. Petersen,
EDI Committee
Past Chair, Board of Directors

Members of the Committee

Elizabeth is the CEO of GlycoNet. She was involved in the GlycoNet initiative since the Letter of Intent stage and served as the Associate Director, Business for the Alberta Glycomics Centre from 2007–2015. Prior to her position with the Centre, she worked as a manager of large-scale and multi-institutional projects with Genome Prairie. In addition to her PhD in biochemistry, Elizabeth has an MBA in biotechnology management.

Dr. Bohlmann holds academic appointments in the Department of Botany, the Department of Forest and Conservation Sciences, and is an Associate of the UBC Wine Research Centre. He is co-director of the UBC Genome Science and Technology (GSAT) graduate program. His research deals with the molecular biochemistry and biology of plant secondary metabolites, genomics of conifers, grapevines, and various medicinal plants, and plant defense against insects.

Dr. Nicolas Doucet obtained his B.S. in biochemistry from Université Laval (B.S. Biochemistry, 2000) and successively completed a master’s degree (M.S. Biochemistry, 2004) and a doctoral thesis in enzyme engineering at the Université de Montréal (Ph.D. Biochemistry, 2007). After completing a protein NMR postdoctoral fellowship in the Department of Chemistry at Yale University (with J. Patrick Loria, 2007-2010), Dr. Doucet joined the faculty at INRS-Institut Armand-Frappier in 2010.

Dr. Lawrence Goodridge is a food microbiologist whose research focuses on the detection, characterization, and control of foodborne pathogens to improve food safety and public health. His work integrates molecular biology, genomics, bioinformatics, and microbiome science to develop innovative approaches for the rapid identification and tracking of bacterial contaminants across the food production chain.

A key area of Dr. Goodridge’s research involves the development of portable, field-deployable microbial diagnostic tools that enable rapid on-site assessment of microbial hazards in food and agricultural environments. Dr. Goodridge also applies next-generation sequencing and metagenomics to study microbial communities in food systems, with the aim of understanding how microbial ecology influences food safety, spoilage, and fermentation. His work contributes to the development of data-driven interventions that reduce the burden of foodborne illness and improve traceability in complex food supply networks.

Dr. Goodridge is also a co-lead of the Guelph Wastewater Epidemiology Lab for Public Health (G.WE.L.P.H.), which conducts wastewater surveillance to monitor the circulation of key respiratory viruses, including SARS-CoV-2, influenza, and respiratory syncytial virus (RSV). By analyzing wastewater samples collected from municipal and institutional sources, the lab provides near real-time data that is shared with public health units, and other health care providers to inform timely responses to emerging public health threats. This work supports a growing global movement toward wastewater-based epidemiology as a non-invasive, cost-effective tool for community-level disease surveillance.

Dr. Sarah Poynter is an Assistant Professor in the Health Sciences department of Wilfrid Laurier University in Waterloo, Ontario, Canada (just outside Toronto!). Sarah first attended SIVB in 2014 as an MSc student under the supervision of Dr. Stephanie DeWitte-Orr and continued to attend from 2015-2017. Sarah returned to SIVB for the 2023 conference and has encouraged student attendance by bringing her MSc student and an undergraduate student to the event, both of whom received student awards to attend and presented posters. Sarah encourages conference attendance in students, with a particular focus on equity-deserving groups and undergraduate students who often are not presented with these opportunities. Sarah is an innate immunologist and cell biologist. Sarah’s areas of expertise lie in immunomodulation using nanotechnology, using cell and molecular techniques. She received her MSc in Integrative Biology from Wilfrid Laurier University and her PhD in Biology from the University of Waterloo. 

Faezeh Jame-Chenarboo is a postdoctoral researcher in Prof. David Vocadlo’s laboratory at Simon Fraser University. She completed her Ph.D. in Prof. Lara Mahal’s laboratory at the University of Alberta, where she led projects on gene regulation of several glycogenes. Her doctoral work contributed to advancing our understanding of RNA-mediated regulatory mechanisms in glycosylation, especially sialylation. In her postdoctoral research, Faezeh is expanding her expertise into new areas at the interface of chemical biology and neurodegenerative diseases.
Beyond her research, Faezeh is dedicated to community building and trainee development. She has served on several trainee communities including the Graduate Students’ Association Labour Relations Committee, GlycoNet Trainee Association Executive Committee (GTA-EC). She looks forward to contributing to the GTA-EC by supporting collaborative, inclusive, and impactful trainee initiatives.

Observer

Dr. Wakarchuk is a Professor from the Department of Biological Sciences at the University of Alberta. The Wakarchuk lab investigates the structure and function of the enzymes which make and degrade various glycoconjugates. This work has been enabling the chemo-enzymatic synthesis of bioactive glycoconjugates both in the laboratory and for industrial projects. The Wakarchuk lab has expertise with both mammalian and bacterial carbohydrate active enzymes for glycan remodelling applications.

Terms of Reference

View Terms of Reference (PDF)

Updates from the Committee

November 2021

Scroll to Top